标题
PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma
作者
关键词
HTLV-1, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Blockade, ATLL
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 98, Issue -, Pages 107870
出版商
Elsevier BV
发表日期
2021-06-18
DOI
10.1016/j.intimp.2021.107870
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions
- (2021) Abolfazl Maghrouni et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia/lymphoma
- (2020) Mai Takeuchi et al. ANNALS OF HEMATOLOGY
- The roles of programmed death ligand 1 in virus-associated cancers
- (2020) Morvarid Golrokh Mofrad et al. INFECTION GENETICS AND EVOLUTION
- KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL).
- (2020) John Kuruvilla et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of PD-1 in Acute and Chronic Infection
- (2020) Jil M. Jubel et al. Frontiers in Immunology
- The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians
- (2020) V. Subbiah et al. ANNALS OF ONCOLOGY
- Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma
- (2019) Yasushi Sawayama et al. AMERICAN JOURNAL OF HEMATOLOGY
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- Recent advances in the clinical development of immune checkpoint blockade therapy
- (2019) Atefeh Ghahremanloo et al. CELLULAR ONCOLOGY
- Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
- (2019) Daniel A. Rauch et al. BLOOD
- A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies
- (2018) Olivier Hermine et al. ADVANCES IN THERAPY
- Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma
- (2018) Yoshitaka Inoue et al. BONE MARROW TRANSPLANTATION
- Clinical Development of PD-1 Blockade in Hematologic Malignancies
- (2018) Matthew J. Pianko et al. CANCER JOURNAL
- Mechanisms of Resistance to PD-1 and PD-L1 Blockade
- (2018) Theodore S. Nowicki et al. CANCER JOURNAL
- Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals
- (2018) Ayako Masaki et al. CANCER SCIENCE
- Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma
- (2018) Yosuke Tanaka et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Expression of PD-1 on peripheral blood Treg cells is related to the diagnosis, prognosis and treatment of T cell non-Hodgkin lymphoma
- (2018) Mengxuan Zuo et al. LEUKEMIA RESEARCH
- PD-1 /PD-L1 checkpoint in hematological malignancies
- (2018) O. Annibali et al. LEUKEMIA RESEARCH
- Rapid Progression of Adult T-Cell Leukemia–Lymphoma after PD-1 Inhibitor Therapy
- (2018) Lee Ratner et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Inhibitor Therapy in Adult T-Cell Leukemia–Lymphoma
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
- (2018) Arash Soltani et al. BIOMEDICINE & PHARMACOTHERAPY
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
- (2018) Steven Horwitz et al. LANCET
- HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice
- (2017) Rashida Ginwala et al. Journal of Neuroimmune Pharmacology
- Early Onset of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T-cell Leukemia/Lymphoma (ATL): Systematic Search and Review
- (2017) Pedro D Oliveira et al. JOURNAL OF TROPICAL PEDIATRICS
- Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
- (2017) Hojabr Kakavand et al. MODERN PATHOLOGY
- PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
- (2017) Tim Wartewig et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction: HTLV-1 bZIP Factor Enhances T-cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors
- (2017) Haruka Kinosada et al. PLoS Pathogens
- IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways
- (2017) Leila Sawada et al. PLoS Pathogens
- Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
- (2017) Yoshimi Enose-Akahata et al. Frontiers in Microbiology
- Comparative Analyses of Signature Genes in Acute Rejection and Operational Tolerance
- (2017) Jeong-Woo Choi et al. Immune Network
- PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma
- (2016) H. Miyoshi et al. BLOOD
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
- (2016) Alexander M. Lesokhin et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002
- (2016) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
- (2016) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran
- (2016) Houshang Rafatpanah et al. JOURNAL OF MEDICAL VIROLOGY
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- (2016) Keisuke Kataoka et al. NATURE
- PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
- (2016) Paul T. Nghiem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients
- (2016) Lucy B. M. Cook et al. Retrovirology
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis
- (2016) Wook Youn Kim et al. VIRCHOWS ARCHIV
- Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
- (2016) L Ratner et al. Blood Cancer Journal
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Human T-cell leukemia virus-associated malignancy
- (2016) Amanda R Panfil et al. Current Opinion in Virology
- Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study
- (2016) Michinori Ogura et al. Lancet Haematology
- Blocking tumor escape in hematologic malignancies: The anti-PD-1 strategy
- (2015) Locke J. Bryan et al. BLOOD REVIEWS
- Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
- (2015) Youko Suehiro et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Treatment of adult T-cell leukaemia/lymphoma
- (2015) Lucy B. Cook et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Treg(s) in Cancer: Friends or Foe?
- (2015) Dominik Wolf et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2015) Scott N. Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Integrated molecular analysis of adult T cell leukemia/lymphoma
- (2015) Keisuke Kataoka et al. NATURE GENETICS
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
- (2015) Vijayakumar Velu et al. Retrovirology
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- ST1926 repression of Tax: ATL targeted treatment?
- (2014) R. Cesaire et al. BLOOD
- High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation
- (2014) N Nakano et al. BONE MARROW TRANSPLANTATION
- Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP
- (2014) A Bazarbachi et al. BONE MARROW TRANSPLANTATION
- Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome
- (2014) X. Ni et al. CLINICAL CANCER RESEARCH
- Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement
- (2014) Nicole M. Chapman et al. IMMUNOLOGIC RESEARCH
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
- (2013) D. Brusa et al. HAEMATOLOGICA
- Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells
- (2013) L. Wang et al. HAEMATOLOGICA
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
- (2013) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
- (2013) Jason R Westin et al. LANCET ONCOLOGY
- PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2
- (2013) Nikolaos Patsoukis et al. MOLECULAR AND CELLULAR BIOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor
- (2013) Masao Matsuoka et al. Current Opinion in Virology
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized Mice
- (2012) B. E. Palmer et al. JOURNAL OF IMMUNOLOGY
- The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases
- (2012) Gabriela Gualco et al. MODERN PATHOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals
- (2012) Yorifumi Satou et al. Retrovirology
- PD-1 Expression on Natural Killer Cells and CD8+ T Cells During Chronic HIV-1 Infection
- (2012) Sonia Norris et al. VIRAL IMMUNOLOGY
- Epidemiological Aspects and World Distribution of HTLV-1 Infection
- (2012) Antoine Gessain et al. Frontiers in Microbiology
- Adult T-Cell Leukemia: A Review of Epidemiological Evidence
- (2012) Masako Iwanaga et al. Frontiers in Microbiology
- How I treat adult T-cell leukemia/lymphoma
- (2011) A. Bazarbachi et al. BLOOD
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)
- (2011) Claire E. Dearden et al. BRITISH JOURNAL OF HAEMATOLOGY
- Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
- (2011) D. J. Andorsky et al. CLINICAL CANCER RESEARCH
- Programmed death-1 (PD-1)/PD-1 ligand pathway–mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders
- (2011) Tomohiro Kozako et al. HUMAN IMMUNOLOGY
- Oral tolerance
- (2011) Howard L. Weiner et al. IMMUNOLOGICAL REVIEWS
- High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey
- (2011) Houshang Rafatpanah et al. JOURNAL OF CLINICAL VIROLOGY
- Reduced Tim-3 Expression on Human T-lymphotropic Virus Type I (HTLV-I) Tax-specific Cytotoxic T Lymphocytes in HTLV-I Infection
- (2011) Nashwa H. Abdelbary et al. JOURNAL OF INFECTIOUS DISEASES
- Long-term study of indolent adult T-cell leukemia-lymphoma
- (2010) Y. Takasaki et al. BLOOD
- Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
- (2010) M. Hishizawa et al. BLOOD
- Clinical significance of B7-H1（PD-L1）expression in human acute leukemia
- (2010) Xiangli Chen et al. CANCER BIOLOGY & THERAPY
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma
- (2010) Lei Ni et al. IMMUNOLOGY AND CELL BIOLOGY
- Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
- (2010) Kazuhito Yamamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy
- (2010) M Matsuoka et al. ONCOGENE
- Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
- (2010) Priya Kannian et al. Viruses-Basel
- PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
- (2008) R. Yamamoto et al. BLOOD
- PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
- (2008) T Kozako et al. LEUKEMIA
- Enhancing SIV-specific immunity in vivo by PD-1 blockade
- (2008) Vijayakumar Velu et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started